• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HAO Lina,CHEN Xiaoxue,LI Xiuyun.Study on the effect of voriconazole and budesonide against Candida albica[J].Journal Of Pharmaceutical Research,2019,38(3):144-147,151[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3311times   Download 3553次 QR Code for this article
Scan with your phone!
伏立康唑与布地奈德联用抗白色念珠菌的作用研究
郝丽娜1,陈小雪2,李秀云1
Font:Larger+|Default|Smaller-
(1.山东大学齐鲁儿童医院,山东 济南 250022;2.青岛大学附属医院,山东 青岛 266000)
摘要:
目的 研究伏立康唑与布地奈德联用的体内、外抗白色念珠菌活性。方法 采用微量稀释法测定两药联用的体外抗真菌作用,并以部分抑菌浓度指数模型和生长差异百分率模型共同地评价两药联合抗真菌作用效果。使用大蜡螟作为感染模型,通过测定感染后大蜡螟的生存率、载菌量和组织病理学改变综合评价两药联用在体内的疗效。结果 与对照组和药物单用组相比,两药联用对耐药白色念珠菌有明显的体外协同作用,但对敏感白色念珠菌无体外协同作用。与对照组和药物单用组相比,两药联用可显著提高感染耐药白色念珠菌的大蜡螟的生存率(P<0.05)、降低载菌量(P<0.05)并减少组织破坏,但两药联用对感染敏感白色念珠菌的的大蜡螟的生存率、载菌量、组织病理学均无显著影响。结论 两药联用对耐药白色念珠菌有显著的体内、外协同作用。
关键词:  伏立康唑  布地奈德  耐药  白色念珠菌
DOI:10.13506/j.cnki.jpr.2019.03.004
基金项目:2017年济南市卫生和计划生育委员会科技计划项目(No.2017-2-20)
Study on the effect of voriconazole and budesonide against Candida albica
HAO Lina1,CHEN Xiaoxue2,LI Xiuyun1
(1.Qilu Children's Hospital of Shandong University, Jinan 250022,China;2.Affiliated Hospital of Qingdao University,Qingdao 266000,China)
Abstract:
Objective To observe the antifungal effects of voriconazole(VRC) combined with budesonide (BUD) against Candida albicans in vivo and in vitro.Methods The in vitro antifungal effects of voriconazole in combination with budesonide against Candida albicans were determined by a broth microdilution method. Fractional inhibitory concentration index (FICI) model and percentage of growth difference (△E) model were used to interpret the antifungal effects in vitro.Using Galleria mellonella as the infection model, the survival rates, fungal burden and histopathology of infected larvae were used to determine the in vivo antifungal effects of voriconazole in combination with budesonide.Results Compared to control and drug alone groups, the combination of voriconazole and budesonide had effects against resistant Candida albicans in vitro, while no synergetic effects were observed for susceptible Candida albicans. Furthermore, the combination of voriconazole and budesonide significantly improved the survival rates (P<0.05), reduce fungal burden (P<0.05) and reduce tissue damage of Galleria mellonella infected with resistant Candida albicans,while no significant effect was found in Galleria mellonella infected with susceptible Candida albicans.Conclusion Voriconazole in combination with budesonide has significantly synergetic effects against resistant Candida albicans in vivo and in vitro.
Key words:  Voriconazole  Budesonide  Resistance  Candida albicans
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.